Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring(2016)
摘要
Asymptomatic ARIA-E was detected in solanezumab-treated and placebo-treated AD patients. ARIA-E occurs infrequently during solanezumab and placebo treatments but may occur repeatedly in some patients.
更多查看译文
关键词
Amyloid-related imaging abnormalities,Alzheimer's disease,Clinical trials
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要